Preliminary BRIUMVI U.S. fourth quarter and full year 2025 net product revenue of approximately $182 million and $594 million, respectively Full Year 2026 target total global revenue of approximately ...

KORU Medical Systems, Inc.KRMD recently announced that it has submitted a 510(k) premarket notification for FDA clearance to use its FreedomEDGE infusion system to deliver PHESGO, a breast cancer ...

KORU Medical has submitted a 510(k) premarket notification to the US Food and Drug Administration (FDA) seeking approval for its FreedomEDGE infusion system. The submission is intended for using the ...

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on ...

Autoimmune thrombocytopenia (AITP) is frequent in patients diagnosed with common variable immunodeficiency (CVID). High dose intravenous immunoglobulin treatment (IVIG) has conventionally been a ...

The Trump administration has instructed states that they must "immediately undo any steps" that were taken to provide full SNAP benefits to low-income Americans, saying states were "unauthorized." The ...

One Equity Partners has exited its investment in InfuCare Rx Inc, a Fairfield, New Jersey-based provider of specialty infusion therapy via a founder-led equity buyback. No financial terms were ...

In critically ill patients with severe metabolic acidaemia (defined as pH ≤ 7.20) and moderate-to-severe acute kidney injury (AKI), intravenous sodium bicarbonate infusion did not reduce all-cause ...

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and ...

The prescribed dosage for Privigen (human immunoglobulin g) may vary depending on a person’s individual treatment plan. Other factors, including your specific diagnosis, body weight, and medical ...